Stimulatory effect of insulin and insulin-like growth factor I on Gi proteins and angiotensin-II-induced phosphoinositide breakdown in cultured bovine adrenal cells

Endocrinology. 1990 Apr;126(4):1867-72. doi: 10.1210/endo-126-4-1867.

Abstract

Recent data have shown that pretreatment of bovine adrenal fasciculata cells with insulin-like growth factor I (IGF-I) or insulin enhances the steroidogenic response to angiotensin II (A-II). In the present work we have studied the effects of both peptides on the first steps of the mechanism of action of A-II and on the amounts of pertussis toxin (PT)-sensitive guanine nucleotide binding proteins (Gi proteins). Both peptides increased A-II-induced phosphoinositide breakdown without modification of either A-II-induced Ca2+ uptake or the A-II-potentiating effect on ACTH-induced cAMP production. The effects of IGF-I at a nanomolar concentration were higher than those induced by insulin at a micromolar concentration, which in turn was higher than those induced by a nanomolar concentration of this peptide. Treatment of cells with pertussis toxin (0.5 microgram/ml) for 24 h reduced by 25% of the A-II-induced phosphoinositide breakdown in control cells and 32% and 28% in cells pretreated with insulin at nanomolar and micromolar concentrations, respectively, but had no significant effect in cells pretreated with IGF-I. No effect of pertussis toxin was observed on A-II-induced Ca2+ uptake or on its potentiating action on ACTH-induced cAMP production. Moreover, both IGF-I and insulin enhanced the amounts of Gi protein(s) evaluated by pertussis toxin ADP-ribosylation or immunoblotting. Again, the effects of insulin at nanomolar concentrations were lower than those induced by the same concentrations of IGF-I or insulin at micromolar concentrations. These results suggest that, in bovine adrenal fasciculata cells, A-II receptors are coupled to the phosphoinositide pathway through pertussis toxin sensitive and insensitive Gp protein(s). Moreover, the findings also indicate that the enhanced A-II responsiveness of IGF-I or insulin treated cells is in part mediated through an increase in the amount of G protein(s).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Glands / cytology
  • Adrenal Glands / metabolism*
  • Adrenocorticotropic Hormone / pharmacology
  • Angiotensin II / pharmacology*
  • Animals
  • Calcium / metabolism
  • Cattle
  • Cells, Cultured
  • Cyclic AMP / biosynthesis
  • Drug Synergism
  • GTP-Binding Proteins / metabolism*
  • Insulin / pharmacology*
  • Insulin-Like Growth Factor I / pharmacology*
  • Pertussis Toxin
  • Phosphatidylinositols / metabolism*
  • Somatomedins / pharmacology*
  • Virulence Factors, Bordetella / pharmacology

Substances

  • Insulin
  • Phosphatidylinositols
  • Somatomedins
  • Virulence Factors, Bordetella
  • Angiotensin II
  • Insulin-Like Growth Factor I
  • Adrenocorticotropic Hormone
  • Cyclic AMP
  • Pertussis Toxin
  • GTP-Binding Proteins
  • Calcium